The T H 22‐mediated IL‐22 deficiency associated with premature ovarian insufficiency
American Journal of Reproductive Immunology · 2023
DOI: 10.1111/aji.13685 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2023. Verfasst von Wenzhe Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Menopause, Premature, Primary Ovarian Insufficiency. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Research question Is deficiency of IL‐22 associated with premature ovarian insufficiency (POI)?
Design
Levels of IL‐22 and IL‐22BP, IL‐22‐producing T cells, and IL22RA1/IL10R2 expression were measured and compared among 29 patients with POI, 42 with precursor stage of POI (pre‐POI) and 46 control women. Correlation of serum IL‐22 and IL‐22 + CD4 + T subsets with ovarian reserve markers were further analyzed.
Results
IL‐22 levels in serum significantly differed among control women and patients with pre‐POI and POI, with the lowest concentrations in POI group ( p = .019). Significant reduction of peripheral CD4 + IL‐22 + T cells was observed in patients with POI ( p = .010), which mainly contributed by decrease of CD4 + IL‐22 + IL‐17 − T H 22 cells ( p = .012) but not T H 17 cells ( p = .125). Levels of serum IL‐22 and IL‐22‐producing CD4 + T subsets were significantly correlated with ovarian reserve markers, including AMH, bilateral AFC, follicle‐stimulating hormone (FSH), and E2 ( p < .05). The specific receptor IL22RA1 expression was marginally reduced in granulosa cells from patients with pre‐POI ( p = .051). No difference of IL‐22BP was observed either in serum ( p = .216) or follicular fluid ( p = .856) among groups.
Conclusions
Our study first demonstrated the significant association between T H 22‐mediated IL‐22 deficiency and ovarian insufficiency, which provide new insights into the autoimmune disturbance and opens new avenues for exogenous IL‐22 administration as potential intervention of POI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine, Shandong University, Jinan, Shandong, China.
- Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong, China.
- Shandong Key Laboratory of Reproductive Medicine, Jinan, Shandong, China.
- Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong, China.
- Shandong Technology Innovation Center for Reproductive Health, Jinan, Shandong, China.
- National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, Shandong, China.
ORCID-Profile: Yingying Qin, Xue Jiao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Zhang, W., Xu, S., Zhang, R., Li, Z., Li, N., Zhang, X., Lu, Y., Bian, Y., Yang, P., Fang, F., Qin, Y., & Jiao, X. (2023). The T H 22‐mediated IL‐22 deficiency associated with premature ovarian insufficiency. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.13685
Vancouver
Zhang W, Xu S, Zhang R, Li Z, Li N, Zhang X, et al. The T H 22‐mediated IL‐22 deficiency associated with premature ovarian insufficiency. American Journal of Reproductive Immunology. 2023. doi:10.1111/aji.13685
BibTeX
@article{Zhang2023,
author = {Zhang, Wenzhe and Xu, Shiru and Zhang, Rongrong and Li, Zhuqing and Li, Nianyu and Zhang, Xiruo and Lu, Yueshuang and Bian, Yuehong and Yang, Ping and Fang, Fang and Qin, Yingying and Jiao, Xue},
title = {The T H 22‐mediated IL‐22 deficiency associated with premature ovarian insufficiency},
journal = {American Journal of Reproductive Immunology},
year = {2023},
doi = {10.1111/aji.13685}
}
EUVIMED